Literature DB >> 7108765

Benzoate-induced changes in glycine and urea metabolism in patients with chronic renal failure.

W E Mitch, S Brusilow.   

Abstract

During acylation of benzoate, glycine nitrogen is incorporated into hippurate which can be readily excreted by the kidney. To determine if glycine and urea metabolism are changed during administration of benzoate to patients with chronic renal failure, 10 g/day of sodium benzoate was given to seven patients with an average estimated glomerular filtration rate of 8 ml/min. Nitrogen balance, the urea nitrogen appearance rate (net urea production rate) and hippurate excretion of each patient were measured during a control period and again during the benzoate period. During benzoate administration, hippurate nitrogen excretion increased by 0.68 +/- 0.05 g of nitrogen per day, equivalent to 70 +/- 5% of the benzoate administered; additional hippurate was excreted subsequently, suggesting that benzoate was virtually completely converted to hippurate. With this conversion, there was a decrease in the urea nitrogen appearance rate of 1.52 +/- 0.43 g of nitrogen per day (P less than .02) so that the serum concentration of urea nitrogen decreased by -19 +/- 3 mg/dl (P less than .011). In spite of the excretion of large amounts of glycine as hippurate, there was no significant changes in plasma concentrations of glycine or serine. This suggests that nitrogenous precursors of urea were used for synthesis of glycine and subsequently hippurate, leading to a reduction in net urea production.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7108765

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.

Authors:  Khushbu K Modi; Malabendu Jana; Susanta Mondal; Kalipada Pahan
Journal:  Neurochem Res       Date:  2015-09-23       Impact factor: 3.996

2.  Excretion of hippuric acid during sodium benzoate therapy in patients with hyperglycinaemia or hyperammonaemia.

Authors:  B A Barshop; J Breuer; J Holm; J Leslie; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders.

Authors:  Arundhati Jana; Khushbu K Modi; Avik Roy; John A Anderson; Richard B van Breemen; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-09       Impact factor: 4.147

Review 4.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

5.  Effect of single oral dose of sodium benzoate on ureagenesis in healthy men and two patients with late onset citrullinaemia.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  A randomized trial to study the comparative efficacy of phenylbutyrate and benzoate on nitrogen excretion and ureagenesis in healthy volunteers.

Authors:  Sandesh C S Nagamani; Umang Agarwal; Allison Tam; Mahshid Azamian; Ann McMeans; Inka C Didelija; Mahmoud A Mohammad; Juan C Marini
Journal:  Genet Med       Date:  2017-10-12       Impact factor: 8.822

7.  Serum and urine metabolomics reveal potential biomarkers of T2DM patients with nephropathy.

Authors:  Mingmei Shao; Hao Lu; Ming Yang; Yang Liu; Peihao Yin; Guowen Li; Yunman Wang; Lin Chen; Qingguang Chen; Cheng Zhao; Qun Lu; Tao Wu; Guang Ji
Journal:  Ann Transl Med       Date:  2020-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.